Paul S. Monroe

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

Gert Van Assche, William J. Sandborn, Brian G. Feagan et al. · Gut · 2006 · 146 citations · Full text

Acute respiratory failure after sodium morrhuate esophageal sclerotherapy

Paul S. Monroe, Calvin Morrow, J. Eugene Millen et al. · Gastroenterology · 1983 · 85 citations

Pulmonary Medicine, Acute Respiratory Failure, Esophagus

The Aminopyrine Breath Test and Serum Bile Acids Reflect Histologic Severity in Chronic Hepatitis

Paul S. Monroe, Alfred L. Baker, John F. Schneider et al. · Hepatology · 1982 · 81 citations · Full text

Hepatology, Biliary Tract, Viral Hepatitis +13

Comparison of Different Methods of Expressing Results of the Aminopyrine Breath Test

Dale A. Schoeller, Alfred L. Baker, Paul S. Monroe et al. · Hepatology · 1982 · 42 citations · Full text

Asthma, Liver Function, Different Methods +23

Hepatic Angiosarcoma

Paul S. Monroe · JAMA · 1981 · 37 citations

Endocrine Oncology, Hepatology, Oral Contraceptives +9